Stallergenes Greer plc announced the appointment of Daniel Smith as Global Head of Information Technology. Daniel has more than 20 years of international experience in Information Technology with extensive expertise in the pharmaceutical industry. He joins Stallergenes Greer after six years at Zoetis Inc. formerly Pfizer Pharmaceuticals International where he was responsible for driving innovation in global infrastructure business technology programs, including pharma-focused enterprise resource planning (ERP) systems, digital e-commerce, and sales force support platforms.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +0.14% | +29.68% |
2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
1st Jan change | Capi. | |
---|---|---|
+29.68% | 0 | |
+16.41% | 79.16B | |
+8.80% | 8.72B | |
-16.83% | 4.79B | |
+47.36% | 4.62B | |
+1.74% | 3.82B | |
+14.51% | 2.33B | |
-26.23% | 2.2B | |
+15.63% | 2.1B | |
-34.87% | 2.04B |
- Stock Market
- Equities
- STAGR Stock
- News Stallergenes Greer
- Stallergenes Greer plc Announces Appointment of Daniel Smith as Global Head of Information Technology